Cardiomyopathy

Welcome to our featured section on cardiomyopathy – an educational hub, pulling together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub is CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos.


Please click below to view 4 additional broadcasts about changing the Status Quo in PE Treatment:

Welcome to our featured section on cardiomyopathy – an educational hub, pulling together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub is CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos. Welcome to our featured section on cardiomyopathy – an educational hub, pulling together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub is CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos. Welcome to our featured section on cardiomyopathy – an educational hub, pulling together the latest clinical data, guidelines, congress updates as well as original video content and expert interviews on the management of cardiomyopathies. Some of the content on this hub is CME-accredited and credits will be available when viewed on Radcliffe Medical Education – our dedicated CME portal. Instructions on how to do so are provided with individual videos.

Close X
Other videos you might like
ccc

Section Advisor

Prof Carolyn Lam Su Ping, Prof Carolyn Lam Su Ping

The Radcliffe diabetes and CVD risk program is supported by an educational grant from Novo Nordisk.

Recent Videos

Video

ESC 2020: Commentary on the EXPLORER-HCM Study

Giuseppe Galati,